翰森制药今日盘中大幅上涨6.17%，引起了市场的广泛关注。
消息面上，港股生物医药股今日全线走高，其中昭衍新药在业绩公布后大涨逾14%，映恩生物-B升逾6%，药明生物、药明康德、泰格医药等亦升逾4%。翰森制药作为生物医药板块的重要成员，在此轮板块普涨行情中同步走强。
此次生物医药板块的集体上涨，主要受到昭衍新药亮眼业绩的提振，市场情绪向好，资金流入该板块，从而带动了包括翰森制药在内的多只个股上涨。
翰森制药今日盘中大幅上涨6.17%，引起了市场的广泛关注。
消息面上，港股生物医药股今日全线走高，其中昭衍新药在业绩公布后大涨逾14%，映恩生物-B升逾6%，药明生物、药明康德、泰格医药等亦升逾4%。翰森制药作为生物医药板块的重要成员，在此轮板块普涨行情中同步走强。
此次生物医药板块的集体上涨，主要受到昭衍新药亮眼业绩的提振，市场情绪向好，资金流入该板块，从而带动了包括翰森制药在内的多只个股上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.